-
3 weeks ago | 
healio.com | Alex Young |Christine Klimanskis |Richard Davidson |Eric D. Donnenfeld
Eric D. Donnenfeld, MD, said that some ophthalmologists downplay the effects of more serious floaters, which he called vitreous opacifications. In this second of a two-part series on vitreous floaters, Healio | OSN spoke with another group of clinicians about differential diagnosis and the finer points of performing vitrectomies.
-
1 month ago | 
crstodayeurope.com | Eric D. Donnenfeld |Michele Corry |David Calkins
Dry eye disease (DED) continues to frustrate surgeons and patients alike with its multifactorial nature and resistance to one-size-fits-all solutions. Although current therapies offer varying degrees of relief, a growing pipeline of investigational treatments is targeting the root causes of ocular surface disease. From addressing meibomian gland dysfunction (MGD) to advancing care for neurotrophic keratopathy (NK), these therapies could reshape the management of complex cases.
-
2 months ago | 
healio.com | Eric D. Donnenfeld |Eamon Dreisbach |Nancy Hemphill
KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, Eric D. Donnenfeld, MD,of OCLI Vision, highlights a new technique for performing penetrating limbal relaxing incisions. “These are simply conventional keratome incisions made at the axis of the cylinder. You need to take a preoperative keratometry, then do vector analysis,” he said. “Then, you can perform either a single or paired incision using a keratome.”
-
Jan 22, 2025 | 
healio.com | Eric D. Donnenfeld |Eamon Dreisbach |Nancy Hemphill
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, Eric D. Donnenfeld, MD,of OCLI Vision, highlights a new technique for performing penetrating limbal relaxing incisions.
-
Jan 14, 2025 | 
crstoday.com | Eric D. Donnenfeld |Michele Corry |David Calkins
We noticed you’re blocking ads Thanks for visiting CRSToday. Our advertisers are important supporters of this site, and content cannot be accessed if ad-blocking software is activated. In order to avoid adverse performance issues with this site, please white list https://crstoday.com in your ad blocker then refresh this page. Need help? Click here for instructions.
-
Jun 1, 2024 | 
healio.com | Eric D. Donnenfeld |Nancy Hemphill |Alex Young |Christine Klimanskis
June 01, 2024 1 min watch VIDEO: Lacrifill provides better dry eye management Add topic to email alerts Please provide your email address to receive an email when new articles are posted on Cornea/External Disease in Ophthalmology. Subscribe Added to email alerts You've successfully added Cornea/External Disease in Ophthalmology to your alerts. You will receive an email when new content is published.
-
May 7, 2024 | 
healio.com | Eric D. Donnenfeld |Anthony DeFino |Christine Klimanskis
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. SEATTLE — In this Healio Video Perspective from the ARVO meeting, Eric D. Donnenfeld, MD, discusses research that investigated Blink Triple Care artificial tears for the treatment of dry eye disease.
-
Apr 10, 2024 | 
eyetube.net | Eric D. Donnenfeld
Punctal Occlusion With Lacrifill Eric Donnenfeld, MD Show Description + Eric Donnenfeld, MD, discusses Lacrifill Canalicular Gel (Nordic Pharma), a crosslinked hyaluronic acid derivative that is FDA-cleared to temporarily block tear drainage by the occlusion of the canalicular system. He highlighted outcomes from the FDA trial during the ASCRS annual meeting in Boston.
-
Apr 8, 2024 | 
healio.com | Eric D. Donnenfeld |Alex Young |Christine Klimanskis
Read more You've successfully added Cornea/External Disease in Ophthalmology to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. BOSTON — In this Healio Video Perspective from the ASCRS meeting, Eric D.
-
Jan 9, 2024 | 
healio.com | Christine Klimanskis |Eric D. Donnenfeld |Nicole R. Fram
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. There are a range of fortified and unfortified antibiotic options for corneal conditions. Eric D. Donnenfeld, MD, and Nicole R. Fram, MD, discussed a corneal infiltrate case and the use of fortified and unfortified antibiotics.
